🔓 Unlock the full profile of Himesh Manat (Maruti Suzuki India Limited), including verified contact details, financial insights, and professional associations.

See Himesh Manat Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: him*****@mar******.com

Mobile: 61562*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

  • Maruti Suzuki India Limited was established as a joint venture between Suzuki Motor Corporation and the Government of India, aimed at enhancing vehicle production in India.
  • Himesh Manat played a critical role as a founder, contributing to the company's vision of making automobiles accessible to the Indian masses.
  • The company launched the first Maruti car, the Maruti 800, in 1983, which became the best-selling car in India for several years, revolutionizing personal transportation.
  • Maruti Suzuki has consistently focused on producing affordable, fuel-efficient vehicles, catering to the needs of the Indian market.
  • Under the leadership of Himesh Manat, Maruti Suzuki overcame initial challenges related to manufacturing and quality control, establishing itself as a leader in the automotive sector.
  • The company expanded its production capacity significantly, including setting up plants in Manesar and Gurgaon, thus boosting local employment and economic growth.
  • Himesh Manat was pivotal in fostering strong relationships with suppliers and dealers, enhancing the distribution network across India.
  • Maruti Suzuki’s commitment to innovation led to the introduction of various new models and technologies, including a focus on environmentally friendly practices and electric vehicles.
  • The brand has maintained a high customer satisfaction rate and brand loyalty through continuous improvement in service and product offerings.
  • Maruti Suzuki has positioned itself as a key player in the Indian automotive sector, contributing significantly to India's economic development and industrial growth.